相似文献
1
Drug eluting stents.
BMJ. 2006 Dec 16;333(7581):1233-4. doi: 10.1136/bmj.39058.554884.BE.
2
Very late thrombosis after implantation of sirolimus eluting stent.
Heart. 2005 Jun;91(6):e45. doi: 10.1136/hrt.2004.056341.
3
Paclitaxel-eluting coronary stents.
N Engl J Med. 2004 May 13;350(20):2099-100; author reply 2099-100. doi: 10.1056/NEJM200405133502018.
4
Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
J Am Coll Cardiol. 2008 Nov 11;52(20):1621-7. doi: 10.1016/j.jacc.2008.08.025.
5
Death caused by simultaneous subacute stent thrombosis of sirolimus-eluting stents in left anterior descending artery and left circumflex artery.
Int J Cardiol. 2010 Apr 1;140(1):e8-11. doi: 10.1016/j.ijcard.2008.11.035. Epub 2008 Dec 30.
6
Which patients receiving warfarin can be treated safely with a drug-eluting stent?
Heart. 2008 Mar;94(3):275-7. doi: 10.1136/hrt.2007.121459.
7
Drug-eluting coronary stents: many meta-analyses, little benefit.
Prescrire Int. 2009 Apr;18(100):70-4.
8
Conversation with an expert. Plavix: what you need to know.
Harv Heart Lett. 2011 Jan;21(5):3.
9
10
Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation.
Eur Heart J. 2008 Apr;29(8):992-1000. doi: 10.1093/eurheartj/ehn046. Epub 2008 Feb 10.
引用本文的文献
1
Antiplatelet drugs: a review of pharmacology and the perioperative management of patients in oral and maxillofacial surgery.
Ann R Coll Surg Engl. 2020 Jan;102(1):9-13. doi: 10.1308/rcsann.2019.0154. Epub 2019 Nov 22.
2
Endodontic management of patients with systemic complications.
J Pharm Bioallied Sci. 2016 Oct;8(Suppl 1):S32-S35. doi: 10.4103/0975-7406.191962.
3
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.
Gut. 2016 Mar;65(3):374-89. doi: 10.1136/gutjnl-2015-311110.
4
Dual anti-platelet therapy and dento-alveolar surgery. How do we manage patients on anti-platelet medication?
Br Dent J. 2014 Dec 5;217(11):E24. doi: 10.1038/sj.bdj.2014.1055.
5
A cautionary tale on the use of antiplatelet treatment following TURP.
BMJ Case Rep. 2014 Apr 4;2014:bcr2013202469. doi: 10.1136/bcr-2013-202469.
6
The Italian Horizon Scanning Project.
Eur J Clin Pharmacol. 2009 Aug;65(8):775-81. doi: 10.1007/s00228-009-0666-z. Epub 2009 Jun 3.
7
A survey of the peri-operative management of urological patients on clopidogrel.
Ann R Coll Surg Engl. 2009 May;91(4):313-20. doi: 10.1308/003588409X391820. Epub 2009 Apr 2.
8
Stent thrombosis: antiplatelets alone won't do the job.
BMJ. 2007 Jan 13;334(7584):57. doi: 10.1136/bmj.39086.931019.1F.
9
Stent thrombosis: patient card on discontinuing clopidogrel is available.
BMJ. 2007 Jan 13;334(7584):57. doi: 10.1136/bmj.39086.917720.1F.
10
Stent thrombosis: consider also low response to antiplatelets.
BMJ. 2007 Jan 13;334(7584):57. doi: 10.1136/bmj.39086.925718.1F.
本文引用的文献
1
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.
J Am Coll Cardiol. 2006 Jun 6;47(11):2164-71. doi: 10.1016/j.jacc.2006.01.068. Epub 2006 May 15.
2
Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy.
Mayo Clin Proc. 2006 May;81(5):641-52. doi: 10.4065/81.5.641.
3
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Circulation. 2006 Mar 21;113(11):1434-41. doi: 10.1161/CIRCULATIONAHA.104.532242. Epub 2006 Mar 13.
4
The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES).
J Am Coll Cardiol. 2005 Jul 19;46(2):253-60. doi: 10.1016/j.jacc.2005.03.069.
5
Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).
Am J Cardiol. 2005 May 15;95(10):1146-52. doi: 10.1016/j.amjcard.2005.01.040.
6
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
JAMA. 2005 May 4;293(17):2126-30. doi: 10.1001/jama.293.17.2126.
7
Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation.
J Am Coll Cardiol. 2005 Mar 15;45(6):947-53. doi: 10.1016/j.jacc.2004.09.079.
8
What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
J Am Coll Cardiol. 2005 Mar 15;45(6):941-6. doi: 10.1016/j.jacc.2004.11.064.
9
Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.
Eur Heart J. 2005 Jun;26(12):1180-7. doi: 10.1093/eurheartj/ehi135. Epub 2005 Feb 23.
10
Meta-analysis comparing drug-eluting stents with bare metal stents.
Am J Cardiol. 2005 Mar 1;95(5):640-3. doi: 10.1016/j.amjcard.2004.10.041.
Zotero 插件